Total U.S. Food and Drug Administration requires painkillers out of the U.S. market, HSBC

the U.S. Food and Drug Administration (FDA) on Friday announced that it has asked propoxyphene analgesics Total abundance (Darvon) to exit the U.S. market.

U.S. Food and Drug Administration pointed out that even in therapeutic doses, these drugs may have toxic effects on the heart. Propoxyphene analgesics mainly by privately held pharmaceutical company Xanodyne Total abundance and Total hold special (Darvocet) are two brand name in the U.S. market, currently the company has agreed to completely stop the sale of two products.

U.S. Food and Drug Administration also asked that all Darfur Fung also stop selling generic drugs. Total abundance was first used by Eli Lilly (LLY) developed in the U.S. market can be traced back to 1957.